Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bo Chen
Institution:
First Affiliated Hospital of Wenzhou Medical University
Observed institutions:
Wenzhou Medical University,
First Affiliated Hospital of Wenzhou Medical University
ORCID:
0000-0002-5490-3980
Observed ORCID:
0000-0002-5490-3980
OpenAlex ID:
A5023969176
Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
·
Clinical Cancer Research
·
60
Incidence, Risk Factors, and Nomogram of Transfusion and Associated Complications in Nonfracture Patients following Total Hip Arthroplasty
2020
·
Yuanhe Wang
, Cui Wang
, et al.
·
BioMed Research International
·
5
PDF
A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?
2024
·
Lixuan Chen
, Chenyang Jin
, et al.
·
British Journal of Radiology
·
2
PDF
Supplementary Table S2 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
·
1
Abstract 2772: Noninvasive artificial intelligence system for prediction of lenvatinib based therapeutic regimens response and outcome in unresectable hepatocellular carcinoma.
2026
·
Bo Chen
, Yuqian Gan
, et al.
·
Cancer Research
Data from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Data from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S3 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S6 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S4 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S1 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S5 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S2 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S4 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Table S3 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Supplementary Figure S1 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
PDF
Supplementary Table S4 from Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
2023
·
Zhiyuan Bo
, Bo Chen
, et al.
Show more works
View as search
Works count:
17
Citation count:
67
H-index:
2
I10-index:
1
Year
Topic
Type